1. Home
  2. GEMI vs PHAR Comparison

GEMI vs PHAR Comparison

Compare GEMI & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gemini Space Station Inc.

GEMI

Gemini Space Station Inc.

HOLD

Current Price

$5.74

Market Cap

666.3M

Sector

N/A

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$10.92

Market Cap

793.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEMI
PHAR
Founded
2014
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
666.3M
793.4M
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
GEMI
PHAR
Price
$5.74
$10.92
Analyst Decision
Buy
Strong Buy
Analyst Count
9
3
Target Price
$8.31
$38.33
AVG Volume (30 Days)
2.7M
17.0K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
51.86
N/A
EPS
N/A
N/A
Revenue
$179,572,000.00
N/A
Revenue This Year
$35.05
$10.04
Revenue Next Year
$39.56
$2.51
P/E Ratio
N/A
$3,041.22
Revenue Growth
26.31
N/A
52 Week Low
$3.39
$9.62
52 Week High
$26.75
$21.34

Technical Indicators

Market Signals
Indicator
GEMI
PHAR
Relative Strength Index (RSI) 65.09 40.01
Support Level $3.92 $9.62
Resistance Level $6.96 $13.51
Average True Range (ATR) 0.40 0.38
MACD 0.05 -0.04
Stochastic Oscillator 96.75 12.79

Price Performance

Historical Comparison
GEMI
PHAR

About GEMI Gemini Space Station Inc.

Gemini Space Station Inc is engaged on unlocking the next era of financial, creative, and personal freedom. It envisions a future where crypto will redesign the global financial system, the internet, and money in a way that provides greater choice, independence, and opportunity for all. As a trusted bridge between the traditional financial system and the emerging crypto economy, It is providing access for individuals and institutions to a decentralized future that is more open, fair, and secure. Its core exchange product has expanded over time to become a comprehensive platform for its users to engage with the crypto economy, including a derivatives exchange, staking services, an over-the-counter (OTC) trading desk, institutional-grade custody, and others.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: